←Back to Expert Scholars
Translational Medicine / 转化医学Advanced Merkel Cell Carcinoma
Howard Kaufman
MD
🏢Ankyra Therapeutics / Massachusetts General Hospital🌐USA
Chief Medical Officer
75
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Howard Kaufman led development of T-VEC oncolytic virotherapy and has contributed to Merkel cell carcinoma immunotherapy advances. His work bridges translational research and biotech drug development. He has served in leadership roles across academic and industry settings.
Share:
🧪Research Fields 研究领域
Oncolytic virotherapy
Merkel cell carcinoma
Immunotherapy development
Melanoma
T-VEC
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Howard Kaufman 的研究动态
Follow Howard Kaufman's research updates
留下邮箱，当我们发布与 Howard Kaufman（Ankyra Therapeutics / Massachusetts General Hospital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment